Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) affects 5%-15% of women and is the most common cause of hirsutism. Data on the time-course of improvement to suppressive therapy and predictors of that response in PCOS are lacking. The objectives of our study are to determine the long-term response and identify pred...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of women's health (Larchmont, N.Y. 2002) N.Y. 2002), 2018-07, Vol.27 (7), p.892-902
Hauptverfasser:	Ezeh, Uche, Huang, Andy, Landay, Melanie, Azziz, Ricardo
Format:	Artikel
Sprache:	eng
Schlagworte:	Contraceptives, Oral - therapeutic use Cross-Sectional Studies Drug Therapy, Combination Female Hirsutism - therapy Humans Hyperandrogenism - drug therapy Mineralocorticoid Receptor Antagonists - therapeutic use Original Polycystic Ovary Syndrome - drug therapy Retrospective Studies Sex Hormone-Binding Globulin Spironolactone - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!